272 |
Gender Aspects of TB |
07/06/2024 |
TB Comorbidities and special conditions |
273 |
Addressing Gender Inequalities |
07/06/2024 |
TB Comorbidities and special conditions |
356 |
Global Burden of TB-HIV |
07/06/2024 |
TB Comorbidities and special conditions |
538 |
Presumptive Paediatric TB |
07/06/2024 |
TB Comorbidities and special conditions |
579 |
TB-HIV BURDEN |
07/06/2024 |
TB Comorbidities and special conditions |
647 |
Malnutrition among people with TB |
07/06/2024 |
TB Comorbidities and special conditions |
650 |
Tobacco use among people with TB |
07/06/2024 |
TB Comorbidities and special conditions |
668 |
Nutritional Counselling for TB Patients |
07/06/2024 |
TB Comorbidities and special conditions |
682 |
Wellness Activity for TB Patients |
07/06/2024 |
TB Comorbidities and special conditions |
684 |
Psychosocial Support to People affected by TB |
07/06/2024 |
TB Comorbidities and special conditions |
715 |
TB-HIV Bidirectional Screening |
07/06/2024 |
TB Comorbidities and special conditions |
716 |
TB-Diabetes Bidirectional Screening |
07/06/2024 |
TB Comorbidities and special conditions |
717 |
TB-Tobacco Bidirectional Screening |
07/06/2024 |
TB Comorbidities and special conditions |
718 |
TB-COVID Bidirectional Screening |
07/06/2024 |
TB Comorbidities and special conditions |
727 |
Diagnostic Algorithm for EPTB |
07/06/2024 |
TB Comorbidities and special conditions |
728 |
Diagnostic Algorithm for Pediatric TB |
07/06/2024 |
TB Comorbidities and special conditions |
747 |
Management of EPTB |
07/06/2024 |
TB Comorbidities and special conditions |
3197 |
Link ART Centre |
07/06/2024 |
TB Comorbidities and special conditions |
3198 |
ART Centre of Excellence |
07/06/2024 |
TB Comorbidities and special conditions |
3199 |
PMDT Treatment Book |
07/06/2024 |
TB Comorbidities and special conditions |
3200 |
TB Comorbidity Committee |
07/06/2024 |
TB Comorbidities and special conditions |
3201 |
District TB-comorbidity Coordination Committees [DTCC] |
07/06/2024 |
TB Comorbidities and special conditions |
3204 |
National TB-HIV Collaborative Framework |
07/06/2024 |
TB Comorbidities and special conditions |
3205 |
Overview of TB-HIV Collaborative Activities under NTEP |
07/06/2024 |
TB Comorbidities and special conditions |
3206 |
NACP and NTEP Coordination at National, State and District Levels |
07/06/2024 |
TB Comorbidities and special conditions |
3207 |
State AIDS Control Society [SACS] |
07/06/2024 |
TB Comorbidities and special conditions |
3249 |
Quarterly report on TB-HIV Collaborative Activities |
07/06/2024 |
TB Comorbidities and special conditions |
3248 |
Ni-kshay HIV Status Report |
07/06/2024 |
TB Comorbidities and special conditions |
3209 |
Linkage to TB-HIV services in the private sector |
07/06/2024 |
TB Comorbidities and special conditions |
3250 |
Performance Indicators and Targets for TB-HIV Collaborative Activities |
07/06/2024 |
TB Comorbidities and special conditions |